Your session is about to expire
← Back to Search
Intervention for Type 2 Diabetes (MbA Trial)
MbA Trial Summary
This trial will assess the safety of montbretin A for Type 2 Diabetes sufferers: establishing a safe dosage range and any potential side effects.
MbA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MbA Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am taking medication other than vitamins or birth control.I have or had issues with my digestive system, like inflammatory bowel disease.I manage my type-2 diabetes with diet alone.I am between 19 and 65 years old.I have not had surgery in the last 4 weeks.
- Group 1: Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the age criteria of this research limited to persons over twenty years old?
"This research is seeking adult participants aged between 18 and 65."
Are there still opportunities to partake in this experiment?
"According to information posted on clinicaltrials.gov, this particular medical study is no longer accepting patients; it was first published in April 1st 2023 and last updated on April 11th of the same year. However, 888 other trials are actively recruiting for participants as we speak."
To what degree are individuals exposed to risk when taking part in this Intervention?
"In the absence of substantial data, our team at Power has rated Intervention's safety as a 1 on a scale from one to three. This is due to this being Phase 1 trial and hence limited evidence backing its efficacy and safety."
May I be included as part of this medical experiment?
"Those wishing to join this trial must meet the criteria of 18-65 years old with type 2 diabetes. A maximum of 25 patients will be accepted into the experiment."
Share this study with friends
Copy Link
Messenger